biopolymer
hydrogel
wide
use
carrier
therapeut
cell
drug
biomed
applic
howev
convent
hydrogel
inject
gelat
support
infiltr
cell
static
natur
network
structur
develop
uniqu
cellinfiltrat
inject
cii
gelatin
hydrogel
physic
crosslink
weak
highli
dynam
complex
reinforc
limit
chemic
crosslink
enhanc
stabil
demonstr
outstand
properti
cii
gelatin
hydrogel
highli
dynam
network
cii
hydrogel
allow
inject
prefabr
hydrogel
encapsul
cell
drug
therebi
simplifi
administr
surgeri
furthermor
revers
natur
weak
crosslink
enabl
infiltr
migrat
extern
cell
cii
gelatin
hydrogel
therebi
promot
particip
endogen
cell
heal
process
find
show
cii
hydrogel
mediat
sustain
deliveri
small
hydrophob
molecular
drug
eg
icaritin
boost
differenti
stem
cell
avoid
advers
effect
eg
treatment
bone
necrosi
associ
high
drug
dosag
inject
cii
hydrogel
encapsul
mesenchym
stem
cell
msc
drug
icaritin
effici
prevent
decreas
bone
miner
densiti
bmd
promot
situ
bone
regener
anim
model
steroidassoci
osteonecrosi
saon
hip
creat
microenviron
favor
osteogen
differenti
msc
includ
recruit
endogen
cell
believ
first
demonstr
appli
inject
hydrogel
effect
carrier
therapeut
cargo
treat
dysfunct
deep
enclos
anatom
site
via
minim
invas
procedur
variou
natur
synthet
materi
use
potenti
carrier
biomateri
cell
therapeut
agent
tissu
regener
hydrogel
highli
hydrat
polymer
network
ideal
carrier
encapsul
cell
drug
howev
convent
hydrogel
allow
cell
encapsul
base
static
chemic
crosslink
lack
dynam
properti
selfheal
inject
limit
preclud
deliveri
cargo
agent
hydrogel
carrier
anatom
deep
enclos
defect
via
minim
invas
procedur
becom
increasingli
popular
demand
aesthet
appear
expediti
postsurgeri
recoveri
furthermor
rigid
nondegrad
natur
chemic
crosslink
hydrogel
hinder
recruit
infiltr
host
cell
implant
hydrogel
therebi
limit
extent
situ
regener
integr
implant
biomateri
host
tissu
mani
previou
studi
demonstr
fabric
dynam
hydrogel
stabil
revers
physic
crosslink
includ
hydrogen
bond
hydrophob
interact
ionic
interact
coordin
interact
complex
physic
crosslink
hydrogel
exhibit
mani
desir
properti
includ
selfheal
inject
howev
weak
natur
physic
crosslink
stringent
demand
cellfriendli
prepar
studi
report
physic
hydrogel
suffici
cytocompat
stabl
allow
encapsul
longterm
cultur
cell
provid
continu
support
encapsul
cell
vivo
deliveri
studi
develop
uniqu
cellinfiltrat
inject
cii
gelatin
hydrogel
stabil
larg
physic
crosslink
complex
reinforc
limit
chemic
crosslink
scheme
demonstr
outstand
properti
cii
gelatin
hydrogel
cii
gelatin
hydrogel
preform
encapsul
therapeut
cell
drug
first
maintain
cultur
condit
desir
period
inject
target
site
gel
form
prescrib
time
excel
inject
remold
furthermor
revers
physic
crosslink
cii
hydrogel
also
support
infiltr
cell
hydrogel
load
chemoattract
drug
uniqu
capabl
cii
hydrogel
offer
great
conveni
surgic
procedur
significantli
expedit
clinic
oper
evalu
efficaci
cii
gelat
hydrogel
carrier
therapeut
drug
cell
treat
enclos
bone
abnorm
steroidassoci
osteonecrosi
saon
femor
head
steroid
wide
use
treat
variou
clinic
condit
rheumatoid
arthriti
organ
transplant
respiratori
syndrom
howev
longterm
steroid
treatment
may
lead
saon
commonli
affect
larg
joint
hip
surgic
core
decompress
cd
procedur
typic
perform
patient
earli
stage
saon
remov
necrot
bone
implant
bone
substitut
drill
tunnel
prevent
subsequ
decreas
bone
miner
densiti
support
bone
regener
sinc
lack
endogen
stem
cell
aberr
accumul
adipos
tissu
recogn
main
characterist
saon
previou
studi
evalu
feasibl
cii
gelatin
hydrogel
encapsul
mesenchym
stem
cell
msc
hydrophob
small
molecul
icaritin
bone
substitut
treat
rat
saon
scheme
vivo
anim
research
show
msc
icaritinladen
cii
gelatin
hydrogel
prevent
decreas
bone
miner
densiti
bmd
promot
situ
bone
regener
moreov
icaritinladen
hydrogel
enhanc
recruit
infiltr
cell
surround
host
tissu
implant
site
confirm
efficaci
cii
scheme
prepar
cellinfiltrat
inject
cii
gelatin
hydrogel
treatment
saon
cii
hydrogel
carrier
therapeut
cargo
cell
drug
rat
model
hydrogel
promot
situ
regener
best
knowledg
first
studi
demonstr
feasibl
use
inject
hydrogel
encapsul
stem
cell
small
molecul
treat
bone
disord
deep
enclos
anatom
locat
eg
saon
hip
prefabr
cii
hydrogel
adapt
inject
site
geometri
maintain
initi
mechan
properti
inject
gelatin
extens
use
variou
biomed
applic
biocompat
bioactiv
biodegrad
avail
gelatin
hydrogel
especi
use
carrier
materi
therapeut
cell
drug
howev
prepar
convent
chemic
crosslink
gelatin
hydrogel
entail
chemic
modif
gelatin
obtain
hydrogel
brittl
restrict
network
dynam
therefor
studi
develop
strategi
prepar
gelatin
hydrogel
contain
chemic
physic
crosslink
base
unmodifi
gelatin
first
synthes
free
diffus
photocrosslink
acryloyl
acryloyl
group
per
molecul
averag
ie
fraction
bear
one
acryloyl
group
figur
coupl
aromat
residu
gelatin
eg
phenylalanin
tyrosin
tryptophan
via
interact
subsequ
uviniti
polymer
led
cii
hydrogel
exhibit
transit
switch
altern
high
unshad
region
low
shade
region
shear
strain
rheolog
test
c
preform
cii
gelatin
hydrogel
drawn
syring
inject
needl
cultur
plate
well
use
mold
remold
shape
cell
cultur
well
cii
gelatin
hydrogel
sustain
compress
strain
without
ruptur
inject
e
stress
vs
strain
curv
cyclic
compress
test
cii
hydrogel
peak
strain
load
speed
mm
inset
plot
strain
rang
format
gelatin
hydrogel
contain
two
type
crosslink
physic
complex
aromat
residu
gelatin
oligomer
distribut
throughout
entir
hydrogel
network
chemic
crosslink
due
fraction
bear
one
acryloyl
group
among
oligomer
distribut
spars
local
ineffici
reaction
among
bulki
follow
experi
demonstr
gelatin
hydrogel
possess
uniqu
dynam
properti
includ
selfheal
shearthin
inject
cell
infiltr
capabl
due
physic
crosslink
also
show
adequ
stabil
local
chemic
crosslink
support
longterm
cultur
encapsul
cell
hydrogel
therefor
refer
cellinfiltrat
inject
gelatin
hydrogel
cii
gelatin
hydrogel
follow
section
rheolog
measur
demonstr
presenc
physic
chemic
crosslink
within
cii
gelatin
hydrogel
cii
hydrogel
show
obviou
frequencydepend
increas
modulu
figur
indic
involv
physic
complex
gelatin
aromat
group
stabil
hydrogel
network
rheolog
studi
reveal
transit
cii
hydrogel
altern
highlow
shear
strain
scheme
cii
hydrogel
switch
sol
state
high
shear
strain
immedi
recov
gel
state
subsequ
low
shear
strain
figur
moreov
even
repeat
highlow
shear
load
cycl
storag
modulu
cii
hydrogel
consist
recov
pa
freshli
prepar
unload
sampl
pa
figur
slight
reduct
storag
modulu
like
attribut
partial
disrupt
chemic
crosslink
load
excel
shearthin
selfheal
capabl
enabl
inject
cii
hydrogel
without
significantli
compromis
mechan
properti
prefabr
cii
hydrogel
disk
inject
needl
cylindr
model
effici
remold
regain
origin
disk
morpholog
figur
moreov
compress
test
show
inject
significantli
affect
mechan
properti
cii
gelatin
hydrogel
inject
hydrogel
could
still
sustain
compress
strain
without
ruptur
could
noninject
hydrogel
figur
furthermor
first
cycl
cii
hydrogel
exhibit
almost
coincid
stress
versu
strain
curv
obtain
remain
load
cycl
peak
strain
suggest
excel
resist
excess
cyclic
compress
figur
previou
studi
prove
welldesign
inject
hydrogel
could
prevent
encapsul
cell
damag
shear
forc
inject
syring
needl
studi
whether
cii
gelatin
hydrogel
could
maintain
viabil
encapsul
cell
inject
cultur
hmscladen
cii
gelatin
hydrogel
vitro
day
inject
hydrogel
needl
inject
hydrogel
cultur
vitro
anoth
day
figur
show
cell
viabil
still
even
inject
demonstr
effect
protect
encapsul
cell
inject
cii
gelatin
hydrogel
cii
hydrogel
mediat
sustain
deliveri
hydrophob
chemoattract
support
infiltr
cell
sustain
deliveri
small
hydrophob
molecul
via
hydrogel
typic
challeng
hydrophil
natur
larg
mesh
size
hydrogel
network
make
load
longterm
releas
small
hydrophob
molecul
rather
difficult
signific
excess
compar
gelatin
aromat
residu
use
fabric
cii
hydrogel
consider
number
unoccupi
cd
moieti
conjug
hydrogel
network
commonli
use
pharmaceut
industri
improv
solubl
hydrophob
drug
util
empti
caviti
cii
hydrogel
deliv
small
hydrophob
chemic
molecul
icaritin
reduc
saon
incid
inhibit
thrombosi
lipid
deposit
icaritinladen
cii
gelatin
hydrogel
capabl
releas
icaritin
continu
week
figur
therefor
find
demonstr
inject
cii
gelat
hydrogel
serv
promis
deliveri
vehicl
small
hydrophob
molecular
drug
treat
patholog
condit
includ
saon
minim
invas
fashion
previou
research
also
show
anabol
potent
molecul
icaritin
function
chemoattract
induc
direct
migrat
msc
within
short
time
frame
dynam
weak
crosslink
base
complex
cii
gelatin
hydrogel
potenti
support
cell
infiltr
migrat
demonstr
seed
msc
surfac
cii
hydrogel
without
load
icaritin
enzym
might
signific
enough
support
extens
cell
infiltr
within
short
period
h
specul
cell
infiltr
like
facilit
disrupt
weak
crosslink
cii
hydrogel
cellular
forc
therefor
specul
implant
defect
site
icaritinladen
cii
gelatin
hydrogel
promot
recruit
infiltr
endogen
cell
hydrogel
matrix
therebi
speed
repair
regener
bone
defect
cii
hydrogel
attenu
advers
effect
highdosag
corticosteroid
stem
cell
differenti
evalu
efficaci
cii
hydrogel
inject
carrier
therapeut
cell
treat
saon
examin
osteogenesi
msc
encapsul
cii
gelatin
hydrogel
presenc
high
concentr
quantit
analysi
microct
bone
peritunnel
b
within
tunnel
c
space
oneway
anova
tukey
post
hoc
test
use
analyz
data
n
p
p
p
golden
trichrom
stain
bonelik
tissu
within
bone
tunnel
scale
bar
microct
imag
part
stain
part
golden
stain
part
corticosteroid
major
msc
encapsul
cii
gelatin
hydrogel
viabl
spread
adopt
stellat
morpholog
week
cultur
figur
indic
dynam
cii
hydrogel
network
provid
permiss
environ
facilit
interact
evalu
differenti
msc
encapsul
hydrogel
differ
cultur
condit
previou
studi
show
dexamethason
dex
clinic
use
corticosteroid
improv
osteogenesi
msc
low
concentr
promot
adipogenesi
msc
high
concentr
rtpcr
data
inde
show
low
media
concentr
dex
nm
promot
express
osteogen
marker
alp
wherea
high
media
concentr
nm
dex
upregul
express
adipogen
marker
msc
encapsul
hydrogel
figur
contrast
media
supplement
icaritin
effect
suppress
express
adipogen
marker
gene
promot
osteogen
marker
gene
alkalin
phosphatas
alp
encapsul
msc
high
media
concentr
dex
figur
figur
correspond
imag
b
cell
posit
osterix
use
immunofluoresc
stain
data
analyz
oneway
anova
tukey
post
hoc
test
n
c
immunofluoresc
stain
week
saon
surgic
treatment
sd
rat
neg
control
group
figur
repres
western
blot
imag
three
independ
experi
osteogen
marker
osteocalcin
activ
adipogen
marker
prolif
marker
pcna
inflammatori
marker
tyrosinekinas
transmembran
receptor
indic
osteonecrosi
csrc
e
n
per
condit
lane
blank
repair
lane
gel
lane
icaritingel
lane
icaritinmscgel
inject
cii
gelatin
hydrogel
load
msc
icaritin
icaritinmscgel
activ
osteocalcin
signal
inhibit
inflammatori
respons
adipogenesi
quantit
data
shown
figur
f
sequenti
label
newli
form
bone
calcein
green
cg
xylenol
orang
xo
methyl
methacrylateembed
icaritinmscgel
sampl
week
postsurgeri
ob
old
bone
bone
tunnel
g
repres
imag
cg
xo
stain
n
imag
per
group
calcul
bone
format
rate
ob
old
bone
bone
tunnel
quantit
analys
bone
format
rate
week
h
week
postsurgeri
obtain
analyz
imag
part
g
data
analyz
oneway
anova
tukey
post
hoc
test
n
p
scale
bar
part
c
upregul
anoth
osteogen
marker
gene
insignific
specul
gene
express
data
collect
late
time
point
day
typic
upregul
msc
earli
time
point
upon
osteogen
induct
correl
osteogenesi
msc
express
becom
less
signific
late
time
point
furthermor
cii
gelatin
hydrogel
load
bolu
dose
icaritin
h
without
icaritin
supplement
produc
similar
express
level
differenti
marker
gene
receiv
fresh
icaritin
supplement
media
chang
figur
von
kossa
stain
figur
ocn
immunohistochem
stain
figur
show
trend
consist
rtpcr
result
demonstr
cii
gelatin
hydrogel
like
capabl
mediat
sustain
deliveri
small
hydrophob
molecular
drug
eg
icaritin
counteract
advers
effect
eg
bone
necrosi
highconcentr
corticosteroid
long
term
codeliveri
msc
icaritin
via
cii
hydrogel
enhanc
bone
regener
saon
model
evalu
efficaci
cii
gelatin
hydrogel
encapsul
msc
icaritin
boost
bone
regener
saon
model
figur
show
inject
cii
gelatin
hydrogel
help
prevent
decreas
bmd
around
tunnel
compar
nontreat
control
group
hydrogel
implant
blank
icaritinmscgel
group
show
significantli
enhanc
new
bone
format
tunnel
figur
quantit
measur
microct
imag
show
icaritinmscgel
group
exhibit
signific
elev
bvtv
trabecular
number
trabecular
thick
reduct
trabecular
separ
compar
group
peritunnel
nativ
bone
figur
neobon
tissu
insid
tunnel
figur
use
golden
trichrom
stain
also
confirm
bone
tunnel
fill
neobon
icaritinmsc
gel
group
figur
contrast
fibrou
tissu
form
group
without
supplement
icaritin
figur
examin
harvest
sampl
assess
bone
regener
within
drill
tunnel
immunofluoresc
stain
marker
wide
use
identifi
prolifer
cell
show
significantli
posit
cell
tunnel
region
inject
cii
gelatin
hydrogel
load
msc
icaritin
icaritinmsc
gel
compar
either
hydrogel
alon
gel
hydrogel
plu
icaritin
icaritingel
treatment
group
figur
moreov
icaritinmscgel
group
also
exhibit
intens
stain
key
osteogen
marker
osterix
figur
c
week
hydrogel
implant
express
activ
ocn
upregul
icaritinmscgel
group
figur
figur
compar
group
may
contribut
enhanc
bone
format
contrast
express
dramat
decreas
figur
figur
indic
suppress
adipogenesi
consist
previou
vitro
find
figur
icaritinladen
hydrogel
icaritinmscgel
icaritin
gel
also
exhibit
significantli
elev
express
anoth
prolifer
marker
prolifer
cell
nuclear
antigen
pcna
addit
week
figur
figur
regardless
msc
supplement
addit
icaritinmscgel
group
show
slightli
reduc
express
csrc
detriment
factor
identifi
therapeut
target
osteonecrosi
tyrosinekinas
transmembran
receptor
greatli
reduc
icaritin
mscgel
icaritingel
group
indic
potenti
immunoregul
effect
icaritin
report
previou
studi
importantli
find
suggest
icaritin
msc
deliv
cii
hydrogel
potenti
mitig
foreign
bodi
respons
biomateri
implant
therebi
facilit
translat
applic
use
calcein
green
cg
xylenol
orang
xo
dynam
assess
bone
format
rate
week
postsurgeri
found
treatment
hydrogel
alon
gel
affect
bone
format
within
bone
tunnel
figur
incorpor
icaritin
inject
hydrogel
icaritingel
significantli
increas
bone
format
rate
compar
either
blank
repair
gel
group
figur
encapsul
exogen
msc
icaritin
hydrogel
icaritin
mscgel
enhanc
bone
format
defect
site
figur
data
demonstr
cii
gelatin
hydrogel
excel
carrier
cell
hydrophob
drug
promot
situ
bone
regener
treat
saon
deliveri
icaritin
cii
hydrogel
facilit
recruit
endogen
cell
expedit
heal
saon
vivo
vitro
data
demonstr
icaritinladen
cii
gelatin
hydrogel
attract
msc
infiltr
migrat
hydrogel
figur
evalu
cell
recruit
vivo
immedi
core
decompress
surgeri
treatment
hydrogel
inject
creat
tunnel
inject
spiolabel
msc
million
cell
media
ipsilater
tibia
limb
six
week
postsurgeri
spiolabel
msc
hardli
found
within
around
tunnel
hydrogel
implant
blank
blank
hydrogel
implant
gel
figur
howev
significantli
spiolabel
msc
found
within
around
tunnel
inject
hydrogel
contain
either
icaritin
alon
icaritin
gel
msc
icaritin
icaritinmscgel
figur
consist
previou
find
icaritin
directli
promot
migrat
msc
upregul
express
vascular
cell
adhes
data
demonstr
icaritinladen
cii
gelatin
hydrogel
recruit
endogen
msc
surround
tissu
migrat
bone
defect
therebi
promot
new
bone
format
collect
demonstr
uniqu
inject
hydrogel
desir
properti
includ
eas
prepar
unscath
mechan
properti
inject
sustain
deliveri
small
hydrophob
molecular
drug
inject
encapsul
cell
furthermor
dynam
physic
crosslink
hydrogel
enabl
infiltr
migrat
cell
surround
environ
speed
situ
bone
regener
saon
anim
model
inject
hydrogel
easili
custom
carri
differ
portfolio
therapeut
drug
cell
treat
wide
array
clinic
condit
via
minim
invas
procedur
deep
enclos
anatom
locat
author
contribut
qf
jx
contribut
equal
author
declar
compet
financi
interest
